InvestorsHub Logo

north40000

08/16/18 3:24 PM

#1676 RE: Ruffieruff #1675


https://www.yahoo.com/news/fda-approves-teva-generic-epipen-182901627.html

"Shares of Teva Pharmaceuticals were climbing on the news while Mylan shares were lower. Adamis Pharmaceuticals’ shares were lower. In July, Adamis was granted U.S. approval to sell an EpiPen rival. It will announce the pricing of the product in the second half of the year, according to Reuters."

Just a bit late, eh?